Medicine manufacturers, including companies producing medicines domestically, are getting paid up to four times as much for their products abroad than in Ireland, new analysis shows. The authors of the Medicine Shortages Index, Azure Pharmaceuticals,… Read More »Essential medicine shortages: scale of price differential between Ireland and neighbouring countries published
212 different medicines needed by Irish patients are currently out of stock, an increase of 25 on last month as the country’s medicine supply chain and pricing challenges continue to impact healthcare on a daily… Read More »Medicines Shortages Index finds Irish patients unable to access 212 medicines as widespread shortages increase
The Medicine Shortage Index, issued today by Azure Pharmaceuticals, analyses data published by the Health Products Regulatory Authority (HPRA). Our analysis underlines the scale of medicine shortages at present. 187 different medicines used by Irish… Read More »Medicine Shortage Index shows Ireland is facing a shortage of 187 different medicines in December
Shortages in medicines, such as those used for treating adverse menopause symptoms, are growing rapidly in Ireland. It is an epidemic that is contributing to the suffering of large segments of the population without any… Read More »It is more than just an increase in demand that is causing the shortage of essential medicines
It is inevitable that the Irish medicine supply chain will face disruption and shortages due to Covid-19, and it is likely that these shortages will manifest sooner than we think. Months, rather than days or… Read More »We can save the Irish medicine cabinet from Covid-19 now – but we need to rethink our approach to the supply chain
Pharma industry veteran Sandra Gannon has set up a new business to tackle supply shortages of common drugs in Ireland.
New Irish pharma company Azure Pharmaceuticals launches with focus on medicine shortages.
Azure’s focus will be on prescription medicines, those older, off-patent medicines which have disappeared or are at risk of disappearing from the market.
The HPRA publishes a list of shortages currently affecting the Irish market that have been notified to them and that may have a medium or high impact on patients. This list can be found here.